Most Viewed Articles

Articles Information
Articles Fulltext downloads PDF downloads
Editorial: Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_7_2019
4,389 3,882
Editorial: Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_8_2019
2,892 3,758
Original Article: Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_1_2019
2,775 3,312
Review Article: Biomarkers in immuno-oncology: A review article
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
DOI:10.25259/IJMIO-6-2019
3,386 2,380
Original Article: Indian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort Study
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_15_2019
2,449 3,139
Review Article: Immunotherapy in esophageal cancer – An update
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
DOI:10.25259/IJMIO-5-2019
3,022 2,344
Editorial: Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI:10.25259/IJMIO_23_2019
2,688 2,663
Brief Commentary: Myths in oncology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May
DOI:10.25259/IJMIO_37_2020
4,129 959
Review Article: Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May
DOI:10.25259/IJMIO_36_2020
4,201 861
Short Communication: Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI:10.25259/IJMIO_30_2020
4,111 950
Review Article: A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May
DOI:10.25259/IJMIO_2_2021
4,036 926
Case Report: Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_2_2019
2,749 2,197
Review Article: Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI:10.25259/IJMIO_17_2019
2,383 2,519
Editorial: Nanobyte
PDF IconPDF New Window Icon 
Year: 2018, Volume: 3, Issue: 2, July-September
DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20183224
0 4,656
Review Article: Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI:10.25259/IJMIO_18_2019
2,188 2,341
Review Article: The Cancer Genomic Atlas – “TO CONQUER CANCER”
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May
DOI:10.25259/IJMIO_28_2020
4,159 292
Case Report: Metastatic endometrial carcinoma responsive to pembrolizumab
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI:10.25259/IJMIO_18_2020
2,684 1,659
Original Article: Correlation of Biomarkers and Frozen Section Diagnosis with Paraffin Histopathological Diagnosis in Suspected Ovarian Cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_6_2019
1,912 2,363
Review Article: Cancer immunotherapy
PDF IconPDF New Window Icon 
Year: 2018, Volume: 3, Issue: 2, July-September
DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20183227
0 4,247
Review Article: Convalescent Plasma Therapy for COVID-19 still has the potential to save lives – The ICMR PLACID study dissected
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI:10.25259/IJMIO_31_2020
2,791 1,316
Review Article: Immune profile of tumor and chemotherapy
PDF IconPDF New Window Icon 
Year: 2018, Volume: 3, Issue: 2, July-September
DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20183228
0 3,940
Case Report: An unusual synchronous association of chronic myeloid leukemia with carcinoma tongue
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
DOI:10.25259/IJMIO-7-2019
1,640 2,260
Review Article: Is continuous infusion of high-dose ifosfamide, a safe option? Drug review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI:10.25259/IJMIO_21_2019
2,766 1,122
Original Article: Evaluation of prevalence and prognostic significance of human epidermal growth factor receptor 2/neu expression in carcinoma endometrium
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI:10.25259/IJMIO_20_2019
1,952 1,933
Editorial: Changing face of genomics in cancer medicine: Which “avatar” to treat?
PDF IconPDF New Window Icon 
Year: 2016, Volume: 1, Issue: 1, October-December
DOI:10.18203/issn.2456-3994.IntJMolImmunoOncol20164381
0 3,843